Luorescence in fluorescently labeled tissue. J Histochem Cytochem 1999, 47:719?30. Pimplikar SW, Suryanarayana
Luorescence in fluorescently labeled tissue. J Histochem Cytochem 1999, 47:719?30. Pimplikar SW, Suryanarayana A: Detection of APP intracellular domain in brain tissue. Methods Mol Biol 2011, 670:85?1. Anisman H, Gibb J, Hayley S: Influence of continuous infusion of interleukin1-beta on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression. Psychopharmacology 2008, 199:199?44. Hanisch UK, Kettenmann H: Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007, 10:1387?394. Ghosal K, Stathopoulos A, Pimplikar SW: APP intracellular domain impairs adult neurogenesis in transgenic mice by inducing neuroinflammation. PLoS One 2010, 5:e11866. Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA, Lanier LM, Yuan LL, Ashe KH, Liao D: Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 2010, 68:1067?081. Perry VH, Nicoll JA, Holmes C: Microglia in neurodegenerative disease. Nat Rev Neurol 2010, 6:193?01. Rossi D, Volterra A: Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res Bull 2009, 80:224?32. Fuller S, Steele M, M ch G: Activated astroglia during chronic inflammation in Alzheimer’s disease o they neglect their neurosupportive roles? Mutat Res 2010, 690:40?9. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991, 82:239?59. Grammas P, Yamada M, Zlokovic B: The cerebromicrovasculature: a key player in the pathogenesis of Alzheimer’s disease. J Alzheimers Dis 2002, 4:217?23. Weller RO, Preston SD, Subash M, Carare RO: Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimers Res Ther 2009, Mangafodipir (trisodium) site pubmed ID:http://www.ncbi.nlm.nih.gov/pubmed/28859980 1:6. Arnaud L, Robakis NK, Figueiredo-Pereira ME: It may take inflammation, phosphorylation and ubiquitination to `tangle’ in Alzheimer’s disease. Neurodegener Dis 2006, 3:313?19. Holmes C, Cunningham C, Zotova E, Culliford D, Perry VH: Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology 2011, 77:212?18. Herbomel P, Thisse B, Thisse C: Zebrafish early macrophages colonize cephalic mesenchyme and developing brain, retina, and epidermis through a M-CSF receptor-dependent invasive process. Dev Biol 2001, 238:274?88. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M: Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841?45. Colton CA, Chernyshev ON, Gilbert DL, Vitek MP: Microglial contribution to oxidative stress in Alzheimer’s disease. Ann N Y Acad Sci 2000, 99:292?07. Flanary BE, Streit WJ: Progressive telomere shortening occurs in cultured rat microglia, but not astrocytes. Glia 2004, 45:75?8. Yun HJ, Yoon JH, Lee JK, Noh KT, Yoon KW, Oh SP, Oh HJ, Chae JS, Hwang SG, Kim EH, Maul GG, Lim DS, Choi EJ: Daxx mediates activation-induced cellKrstic et al. Journal of Neuroinflammation 2012, 9:151 http://www.jneuroinflammation.com/content/9/1/Page 23 of48.49.50.51.52.53.54. 55.56.57.58.59. 60. 61. 62. 63.death in microglia by triggering MST1 signalling. EMBO J 2011, 30: 2465?476. Streit WJ, Braak H, Xue QS, Bechmann I: Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease. Acta Neuropathol 2009, 118:475.